Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma

NCT00012064 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: therapeutic autologous dendritic cells

Sponsor

Lisata Therapeutics, Inc.